Clinical Trial Update: Beta-Hydroxybutyrate Feasibility Treating IBD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 feasibility trial assessing beta-hydroxybutyrate for Crohn's disease and inflammatory bowel disease; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Inflammatory Bowel Disease

Drugs mentioned

• beta-hydroxybutyrate (beta-hydroxybutyrate)

Snippet

Sponsor: University of Texas at Austin | Conditions: Crohn's Disease, Inflammatory Bowel Diseases | Phase 1, Phase 2 | Status: RECRUITING